Evidence Hub

Upper urinary tract infections in adults: about 261 episodes

Abdelmalek R, Kilani B, Kanoun F, Ammari L, Benaissa HT, Goubontini A, Zouiten F, Chaabane TB

La Tunisie medicale, 2010

241 participants

Abstract

BACKGROUND: Upper urinary tract infections are frequent. Escherichia coli is the main pathogen identified from community acquired infections.

AIM: We aim to study epidemiologic, clinical and bacterial features of this infection.

METHODS: We identified 261 episodes that occurred in 241 patients. They were 213 females and 48 males aged of 48.75 years. Enterobacteriaceae were the main pathogens isolated in 93.5%: E. coli in 73.3% and Klebsiella pneumoniae in 15.3%. E. coli sensitivity was of 30% for amoxicillin, 98% for cefotaxim, 96% for gentamicin, 90% for ciprofloxacin and 56% for co-trimoxazole. Anterior antibiotic use was associated with low E. coli sensitivity mainly with fluoroquinolones (96 vs 77%) and co-trimoxazole (62 vs 43%). This enhances the role of antibiotic pressure on the resistance emergence.

CONCLUSION: the reasonable use of antibiotics is necessary to limit resistance extent.

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 241 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free